COVID-19 related depression and anxiety among quarantined respondents.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Routledge Country of Publication: England NLM ID: 8807983 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-8321 (Electronic) Linking ISSN: 08870446 NLM ISO Abbreviation: Psychol Health Subsets: MEDLINE
    • Publication Information:
      Publication: <2010-> : Abingdon, Oxon : Routledge
      Original Publication: Chur ; New York : Harwood Academic Publishers ; London : distributed by STBS Ltd., c1987-
    • Subject Terms:
    • Abstract:
      Objective: The outbreak of the coronavirus disease (COVID-19) poses an unprecedented threat to public health. Current measures to control the spread include social distancing and quarantine, which may trigger mental health problems.
      Design and Main Outcome Measures: The sample (N = 1160) constituted three groups: people quarantined in an affected area, unaffected areas, and people not in quarantine. The Center for Epidemiological Studies Depression Scale (CES-D-20) and the Goldberg Depression and Anxiety Scale (GAD-7) were administered as measures of depression and anxiety, respectively. The multi-variant logistic and multiple linear regression identified factors associated with depression and anxiety.
      Results: Probable depression and anxiety were reported by 26.47% and 70.78% of all respondents, respectively. After adjusting for demographic and community variables, quarantined respondents reported a higher likelihood to exhibit symptoms of depression and anxiety than those not quarantined. Respondents living in communities where screening for COVID-19 was required were less likely to report depression and anxiety symptoms.
      Conclusion: The incidence of depression and anxiety among quarantined respondents was significantly higher than that of respondents not quarantined, and twice as common among quarantined respondents in unaffected areas as those in affected areas. Appropriate community screening may reduce the risk of depression and anxiety during an epidemic.
    • Grant Information:
      R01 HL070848 United States HL NHLBI NIH HHS; R01 HL071194 United States HL NHLBI NIH HHS; R01 HL070847 United States HL NHLBI NIH HHS; UL1 TR000128 United States TR NCATS NIH HHS; U01 AG042145 United States AG NIA NIH HHS; U01 AG042168 United States AG NIA NIH HHS; R01 HL070841 United States HL NHLBI NIH HHS; R01 HL070839 United States HL NHLBI NIH HHS; U01 AG027810 United States AG NIA NIH HHS; U01 AG042139 United States AG NIA NIH HHS; R01 HL070842 United States HL NHLBI NIH HHS; U01 AG042124 United States AG NIA NIH HHS; U01 AG042140 United States AG NIA NIH HHS; R01 HL070838 United States HL NHLBI NIH HHS; R01 HL070837 United States HL NHLBI NIH HHS; U01 AG042143 United States AG NIA NIH HHS
    • Contributed Indexing:
      Keywords: COVID-19; China; anxiety; depression; quarantine
    • Publication Date:
      Date Created: 20200623 Date Completed: 20210125 Latest Revision: 20240323
    • Publication Date:
      20240323
    • Accession Number:
      10.1080/08870446.2020.1782410
    • Accession Number:
      32567952